Logo image of MT.AS

ARCELORMITTAL (MT.AS) Stock Fundamental Analysis

AMS:MT - Euronext Amsterdam - LU1598757687 - Common Stock - Currency: EUR

30.48  -1.69 (-5.25%)

Fundamental Rating

4

Overall MT gets a fundamental rating of 4 out of 10. We evaluated MT against 37 industry peers in the Metals & Mining industry. There are concerns on the financial health of MT while its profitability can be described as average. MT is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year MT was profitable.
MT had a positive operating cash flow in the past year.
Of the past 5 years MT 4 years were profitable.
MT had a positive operating cash flow in each of the past 5 years.
MT.AS Yearly Net Income VS EBIT VS OCF VS FCFMT.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B

1.2 Ratios

With a Return On Assets value of 1.50%, MT perfoms like the industry average, outperforming 59.46% of the companies in the same industry.
Looking at the Return On Equity, with a value of 2.72%, MT is in line with its industry, outperforming 56.76% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.46%, MT is in line with its industry, outperforming 54.05% of the companies in the same industry.
Industry RankSector Rank
ROA 1.5%
ROE 2.72%
ROIC 3.46%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MT.AS Yearly ROA, ROE, ROICMT.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

Looking at the Profit Margin, with a value of 2.14%, MT is in line with its industry, outperforming 56.76% of the companies in the same industry.
In the last couple of years the Profit Margin of MT has declined.
The Operating Margin of MT (5.83%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of MT has grown nicely.
Industry RankSector Rank
OM 5.83%
PM (TTM) 2.14%
GM N/A
OM growth 3Y-35.65%
OM growth 5Y25.94%
PM growth 3Y-52.12%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MT.AS Yearly Profit, Operating, Gross MarginsMT.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MT is destroying value.
There is no outstanding debt for MT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MT.AS Yearly Shares OutstandingMT.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B
MT.AS Yearly Total Debt VS Total AssetsMT.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B

2.2 Solvency

MT has a debt to FCF ratio of 25.87. This is a negative value and a sign of low solvency as MT would need 25.87 years to pay back of all of its debts.
With a Debt to FCF ratio value of 25.87, MT perfoms like the industry average, outperforming 48.65% of the companies in the same industry.
MT has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MT (0.18) is better than 75.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 25.87
Altman-Z N/A
ROIC/WACC0.41
WACC8.43%
MT.AS Yearly LT Debt VS Equity VS FCFMT.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B 40B 50B

2.3 Liquidity

MT has a Current Ratio of 1.35. This is a normal value and indicates that MT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.35, MT is doing worse than 70.27% of the companies in the same industry.
MT has a Quick Ratio of 1.35. This is a bad value and indicates that MT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MT (0.59) is worse than 67.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.59
MT.AS Yearly Current Assets VS Current LiabilitesMT.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

More info and screens

3

3. Growth

3.1 Past

MT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.39%.
The earnings per share for MT have been decreasing by -41.48% on average. This is quite bad
The Revenue has decreased by -8.54% in the past year.
Measured over the past years, MT shows a decrease in Revenue. The Revenue has been decreasing by -2.43% on average per year.
EPS 1Y (TTM)-53.39%
EPS 3Y-41.48%
EPS 5YN/A
EPS Q2Q%-55.93%
Revenue 1Y (TTM)-8.54%
Revenue growth 3Y-6.57%
Revenue growth 5Y-2.43%
Sales Q2Q%1.11%

3.2 Future

The Earnings Per Share is expected to grow by 24.00% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 1.38% on average over the next years.
EPS Next Y53.04%
EPS Next 2Y38.47%
EPS Next 3Y24%
EPS Next 5YN/A
Revenue Next Year-0.65%
Revenue Next 2Y1.45%
Revenue Next 3Y1.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MT.AS Yearly Revenue VS EstimatesMT.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B
MT.AS Yearly EPS VS EstimatesMT.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.34, MT is valued correctly.
81.08% of the companies in the same industry are more expensive than MT, based on the Price/Earnings ratio.
MT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.35.
Based on the Price/Forward Earnings ratio of 8.07, the valuation of MT can be described as reasonable.
MT's Price/Forward Earnings ratio is rather cheap when compared to the industry. MT is cheaper than 83.78% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, MT is valued rather cheaply.
Industry RankSector Rank
PE 12.34
Fwd PE 8.07
MT.AS Price Earnings VS Forward Price EarningsMT.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MT is valued a bit cheaper than the industry average as 75.68% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as MT.
Industry RankSector Rank
P/FCF 63.13
EV/EBITDA 5.21
MT.AS Per share dataMT.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MT's earnings are expected to grow with 24.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y38.47%
EPS Next 3Y24%

More info and screens

4

5. Dividend

5.1 Amount

MT has a Yearly Dividend Yield of 3.16%.
Compared to an average industry Dividend Yield of 3.77, MT pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, MT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.16%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MT.AS Yearly Dividends per shareMT.AS Yearly Dividends per shareYearly Dividends per share 2021 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

29.35% of the earnings are spent on dividend by MT. This is a low number and sustainable payout ratio.
DP29.35%
EPS Next 2Y38.47%
EPS Next 3Y24%
MT.AS Yearly Income VS Free CF VS DividendMT.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B
MT.AS Dividend Payout.MT.AS Dividend Payout, showing the Payout Ratio.MT.AS Dividend Payout.PayoutRetained Earnings

More info and screens

ARCELORMITTAL

AMS:MT (3/7/2025, 7:00:00 PM)

30.48

-1.69 (-5.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)05-02 2025-05-02/bmo
Inst Owners20.82%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap25.99B
Analysts80
Price Target31.54 (3.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.16%
Yearly Dividend0.41
Dividend Growth(5Y)N/A
DP29.35%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.35%
Min EPS beat(2)-34.3%
Max EPS beat(2)-12.4%
EPS beat(4)1
Avg EPS beat(4)-13.46%
Min EPS beat(4)-34.3%
Max EPS beat(4)22.07%
EPS beat(8)5
Avg EPS beat(8)26.38%
EPS beat(12)8
Avg EPS beat(12)45.46%
EPS beat(16)11
Avg EPS beat(16)36.52%
Revenue beat(2)0
Avg Revenue beat(2)-3.71%
Min Revenue beat(2)-5.3%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-3.78%
Min Revenue beat(4)-5.3%
Max Revenue beat(4)-2.12%
Revenue beat(8)1
Avg Revenue beat(8)-2.96%
Revenue beat(12)4
Avg Revenue beat(12)-0.46%
Revenue beat(16)5
Avg Revenue beat(16)-1.32%
PT rev (1m)4.87%
PT rev (3m)5.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.99%
EPS NY rev (1m)0.59%
EPS NY rev (3m)-6.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.26%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-3.5%
Valuation
Industry RankSector Rank
PE 12.34
Fwd PE 8.07
P/S 0.45
P/FCF 63.13
P/OCF 5.82
P/B 0.57
P/tB 0.63
EV/EBITDA 5.21
EPS(TTM)2.47
EY8.1%
EPS(NY)3.78
Fwd EY12.39%
FCF(TTM)0.48
FCFY1.58%
OCF(TTM)5.24
OCFY17.19%
SpS67.44
BVpS53.16
TBVpS48.35
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.5%
ROE 2.72%
ROCE 5.39%
ROIC 3.46%
ROICexc 3.83%
ROICexgc 4.13%
OM 5.83%
PM (TTM) 2.14%
GM N/A
FCFM 0.72%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-35.65%
OM growth 5Y25.94%
PM growth 3Y-52.12%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 25.87
Debt/EBITDA 1.38
Cap/Depr 160.3%
Cap/Sales 7.05%
Interest Coverage 250
Cash Conversion 75.93%
Profit Quality 33.38%
Current Ratio 1.35
Quick Ratio 0.59
Altman-Z N/A
F-Score6
WACC8.43%
ROIC/WACC0.41
Cap/Depr(3y)153.41%
Cap/Depr(5y)132.37%
Cap/Sales(3y)6.05%
Cap/Sales(5y)5.33%
Profit Quality(3y)145.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.39%
EPS 3Y-41.48%
EPS 5YN/A
EPS Q2Q%-55.93%
EPS Next Y53.04%
EPS Next 2Y38.47%
EPS Next 3Y24%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.54%
Revenue growth 3Y-6.57%
Revenue growth 5Y-2.43%
Sales Q2Q%1.11%
Revenue Next Year-0.65%
Revenue Next 2Y1.45%
Revenue Next 3Y1.38%
Revenue Next 5YN/A
EBIT growth 1Y-25.41%
EBIT growth 3Y-39.88%
EBIT growth 5Y22.88%
EBIT Next Year97.14%
EBIT Next 3Y32.8%
EBIT Next 5Y19.22%
FCF growth 1Y-85.26%
FCF growth 3Y-59.84%
FCF growth 5Y-28.87%
OCF growth 1Y-36.53%
OCF growth 3Y-21.18%
OCF growth 5Y-4.24%